Andrade Robert

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$1.06M

Insider Activity of Andrade Robert

According to the SEC Form 4 filings, Andrade Robert, being in a position of

  1. CHIEF FINANCIAL OFFICER at Fennec Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 57950 shares for $621,786,
    over all time since 2022-12-28, has bought 12500 shares for $0, and sold 104950 shares for $1.06M.

The largest sale of all time was on 2024-01-04 and amounted to 15000 shares of Fennec Pharmaceuticals Inc. for $159,600.

Biography of Andrade Robert

No biography is available at this moment.

2024-04-01PurchaseFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
12,500
–
$0$0-43.63%
2024-03-26SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
13,975
0.0517%
$10.90$152,346-43.72%
2024-03-25SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
13,975
0.0517%
$11.00$153,690-44.18%
2024-01-05SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
15,000
0.0563%
$10.41$156,150-34.01%
2024-01-04SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
15,000
0.0563%
$10.64$159,600-35.21%
2023-06-30SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
7,500
0.0282%
$8.82$66,150-2.04%
2023-06-29SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
7,500
0.0286%
$8.97$67,275-1.92%
2023-06-28SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
10,000
0.0364%
$8.99$89,900-5.81%
2022-12-30SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
5,500
0.021%
$9.61$52,867-12.6%
2022-12-29SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
5,500
0.0207%
$9.57$52,661-13.27%
2022-12-28SaleFennec Pharmaceuticals Inc.
FENC
CHIEF FINANCIAL OFFICER
11,000
0.0422%
$9.61$105,760-11.91%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.